Lucas Melero Gavilha

CV Lattes ORCID

Universidade de São Paulo (USP). Faculdade de Ciências Farmacêuticas de Ribeirão Preto (FCFRP) (Institutional affiliation from the last research proposal)
Birthplace: Brazil

Has experience in Pharmacy, focusing on Pharmaceutical Medicinal Chemistry (Source: Lattes Curriculum)

News published in Agência FAPESP Newsletter about the researcher

More items Less items

TITULO

Articles published in other media outlets ( ):

More items Less items

VEICULO: TITULO (DATA)

Scholarships in Brazil

Ongoing (most recent)

Abstract
Triple negative breast cancer (TNBC) is the subtype with the worst prognosis and highest lethality among other types of breast cancer, as it is not responsive to the hormones progesterone and estrogen, and does not present human epidermal growth factor receptor-2 ( HER2). This subtype represents 15 to 20% of all breast cancer diagnoses, with a mortality rate of 40% in the five years follo…
DEVELOPMENT OF THERAPEUTIC CANDIDATES FOR TRIPLE NEGATIVE BREAST CANCER BASED ON MINOR GROOVE DNA BINDING AND HISTONE DEACETYLASE INHIBITION, BP.IC

Virtual Library in numbers * Updated data on August 23, 2025

Total / Available in English

1 / 1	Ongoing scholarships in Brazil

Associated processes

Most frequent collaborators in research granted by FAPESP

Flavio da Silva Emery

Keywords used by the researcher

Chemistry Physical Sciences and Mathematics

Please report errors on the page using this form.

Short URL

Abstract